An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer

Bladder cancer is among the five most common cancers diagnosed in the Western world and causes significant mortality and morbidity rates in affected patients. Therapeutic options to treat the disease in advanced muscle-invasive bladder cancer (MIBC) include cystectomy and chemotherapy. Neoadjuvant c...

Descripción completa

Detalles Bibliográficos
Autores principales: Xylinas, Evanguelos, Hassler, Melanie R., Zhuang, Dazhong, Krzywinski, Martin, Erdem, Zeynep, Robinson, Brian D., Elemento, Olivier, Clozel, Thomas, Shariat, Shahrokh F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039423/
https://www.ncbi.nlm.nih.gov/pubmed/27598218
http://dx.doi.org/10.3390/biom6030037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039423/
https://www.ncbi.nlm.nih.gov/pubmed/27598218
http://dx.doi.org/10.3390/biom6030037

Ejemplares similares